Lanean...
ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63
BACKGROUND: Rare prostate carcinomas aberrantly express p63 and have an immunophenotype intermediate between basal and luminal cells. Here, we performed gene expression profiling on p63-expressing prostatic carcinomas and compared them to usual-type adenocarcinoma. We identify ETS2 as highly express...
Gorde:
| Argitaratua izan da: | Prostate |
|---|---|
| Egile Nagusiak: | , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6818503/ https://ncbi.nlm.nih.gov/pubmed/29761525 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23646 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|